Viewing Study NCT00903656


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-01-01 @ 8:19 PM
Study NCT ID: NCT00903656
Status: TERMINATED
Last Update Posted: 2013-12-24
First Post: 2009-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module